Main navigation

• Home
• About us
• News
  • 2001
  • 2002
  • 2003
  • 2004
  • 2005
  • 2006
  • 2007
  • 2008
  • 2009
  • 2010
• Products
• R&D
• Responsibility
• Contact us
• Careers
• Sitemap

• Pages
• 1
• 2
• 3
• Next

• • Feb 1, 2010
  • AstraZeneca PLC Fourth Quarter and Full Year Results 2009  
• • Nov 3, 2009
  • AstraZeneca PLC Third Quarter & Nine Months Results 2009  
• • Oct 21, 2009
  • In the battle against cancer, ‘future progress depends on personalisation of healthcare’ says AstraZeneca Chief Executive  
• • Oct 16, 2009
  • Driving innovation through dynamic collaboration in Asia  
• • Sep 17, 2009
  • Phase III head to head trial showed BRILINTA reduced cardiovascular death and heart attacks over clopidogrel in Acute Coronary Syndromes patients.  
• • Sep 9, 2009
  • Collaboration in Innovation Drives to Future Success Ground-breaking Ceremony Held for AstraZeneca China Zhangjiang Site  
• • Jul 6, 2009
  • IRESSATM (GEFITINIB) RECEIVES MARKETING AUTHORISATION FOR THE TREATMENT OF NON-SMALL CELL LUNG CANCER IN EUROPE  
• • May 16, 2009
  • Run For A Better Tomorrow--2009 AstraZeneca-CIIC Charity Run Kicks Off on May.16th  
• • May 6, 2009
  • Research Fund Set up By State Key Lab of Respiratory Disease and AstraZeneca  
• • Apr 6, 2009
  • Expert Talk in Breast Cancer Care  

• Pages
• 1
• 2
• 3
• Next

• Advanced search

Quick links

• Careers
• AstraZeneca iHeart
• AstraZeneca Anaesthesia
• AstraZeneca Arimidex
• AstraZeneca Seroquel
• AstraZeneca Corporate

Page tools

• Print
• Bookmark this page